Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 5:02 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 193–216 of 328 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Fetal Complications Clear all

Conditions: Down Syndrome (Trisomy 21), Edwards Syndrome (Trisomy 18), Patau Syndrome (Trisomy 13), Turner Syndrome
Interventions: Not listed
Lead sponsor: Sequenom, Inc.; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 1,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 7
States / cities: La Jolla, California • San Diego, California • San Jose, California + 4 more

Conditions: Gestational Diabetes, Maternal Complication of Pregnancy
Interventions: Continuous Glucose Monitor, Routine Care; Device · Other
Lead sponsor: Yale University; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 65 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2024
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Glucosephosphate Dehydrogenase Deficiency, Hyperbilirubinemia, Hemolytic Disease of Newborn
Interventions: tin mesoporphyrin; Drug
Lead sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); NIH
Eligibility: 0 Years to 24 Hours
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 1999
U.S. locations: 2
States / cities: Boston, Massachusetts • New York, New York

Conditions: Risk for an Alcohol-Exposed Pregnancy, Hazardous Alcohol Use, Risk for Unintended Pregnancy
Interventions: Brief Motivational Counseling; Behavioral
Lead sponsor: Centers for Disease Control and Prevention; Federal
Eligibility: 18 Years to 44 Years · Female only
Enrollment: 1,200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2004
U.S. locations: 11
States / cities: Fort Lauderdale, Florida • Dayton, Texas • Houston, Texas + 1 more

Conditions: Congenital Heart Disease, Viremia, Virus Diseases, Enterovirus, Enterovirus Infections, Heart Defects, Congenital, Heart Diseases, Prenatal Infection, Diabetes, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 1, Diabetes Mellitus, Pregnancy in Diabetic, Pregnancy Complications, Prenatal
Interventions: Stool and Blood Specimen Collection, Follow-up Medical Record Review; Other
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 114 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2023
U.S. locations: 2
States / cities: St Louis, Missouri

Conditions: Trisomy 13, Trisomy 18, Trisomy 21, Sex Chromosome Abnormalities
Interventions: Not listed
Lead sponsor: Natera, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 354 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2019
U.S. locations: 6
States / cities: San Carlos, California • San Diego, California • New York, New York + 2 more

Conditions: Fetal Membranes, Premature Rupture, Preterm Premature Rupture of the Membranes, Oligohydramnios, Premature Birth
Interventions: There is no intervention associated with this study.; Other
Lead sponsor: American Alliance for pProm Support; Other
Eligibility: 14 Years to 55 Years · Female only
Enrollment: 3,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2030
U.S. locations: 1
States / cities: Denver, Colorado

Conditions: Persistent Fetal Circulation Syndrome, Diaphragmatic Hernia, Meconium Aspiration, Sepsis
Interventions: Not listed
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 1 Day to 30 Days
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2007
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Intrauterine Fetal Demise
Interventions: Misoprostol; Drug
Lead sponsor: Gynuity Health Projects; Other
Eligibility: Female only
Enrollment: 153 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2011
U.S. locations: 4
States / cities: Palo Alto, California • Newark, Delaware • Chicago, Illinois + 1 more

Conditions: Complications; Cesarean Section, Hypotension
Interventions: Various sitting time; Other
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: Female only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Pregnancy Outcome Trends in Low-resource Geographic Areas
Interventions: There is no intervention associated with the parent MNHR study. For the MNHR COVID sub-study, participants will be asked to provide a blood specimen at or near delivery.; Other
Lead sponsor: NICHD Global Network for Women's and Children's Health; Network
Eligibility: Not listed
Enrollment: 950,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2030
U.S. locations: 8
States / cities: Birmingham, Alabama • Aurora, Colorado • Indianapolis, Indiana + 5 more

Conditions: Seizures, Disorder of Fetus or Newborn
Interventions: Low dose levetiracetam, High dose levetiracetam; Drug
Lead sponsor: Richard H. Haas; Other
Eligibility: 1 Minute to 14 Days
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2011
U.S. locations: 1
States / cities: San Diego, California

Conditions: Pregnancy Related
Interventions: Elafibranor; Drug
Lead sponsor: Ipsen; Industry
Eligibility: Female only
Enrollment: 3 participants
Timeline: 2026 – 2039
U.S. locations: 1
States / cities: Wilmington, North Carolina

Conditions: Congenital Heart Disease, Disorder of Fetus or Newborn
Interventions: methylprednisolone (IVMP), methylprednisolone (two doses IVMP); Drug
Lead sponsor: Medical University of South Carolina; Other
Eligibility: Up to 30 Days
Enrollment: 77 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2011
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Chagas Disease
Interventions: Nifurtimox (BAYA2502); Drug
Lead sponsor: Bayer; Industry
Eligibility: Female only
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2032
U.S. locations: 1
States / cities: Multiple Locations, West Virginia

Conditions: Preterm Birth, Pregnancy, Fetal Growth Abnormalities
Interventions: Not listed
Lead sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); NIH
Eligibility: 18 Years and older · Female only
Enrollment: 3,650 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1997 – 2016
U.S. locations: 2
States / cities: Detroit, Michigan • Royal Oak, Michigan

Conditions: Fetal Alcohol Spectrum Disorders
Interventions: My Health Coach app; Behavioral
Lead sponsor: University of Rochester; Other
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Perinatal Depression, Perinatal Anxiety, Prenatal Stress
Interventions: Patient Navigation, Adapted Cognitive-Behavioral Therapy; Behavioral
Lead sponsor: Children's National Research Institute; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 700 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Respiratory Distress Syndrome, Newborn, Respiratory Distress Syndrome in Premature Infant, Transient Tachypnea of the Newborn, Meconium Aspiration Syndrome, Pneumonia Neonatal, Hyaline Membrane Disease, Pneumothorax, Respiratory Distress Neonatal
Interventions: Not listed
Lead sponsor: Mayo Clinic; Other
Eligibility: 32 Weeks to 41 Weeks
Enrollment: 500 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Infant Malnutrition, Light-For-Dates With Signs of Fetal Malnutrition, Premature, Nutrition Disorder, Infant
Interventions: DHA; Dietary Supplement
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 24 Hours to 72 Hours
Enrollment: 152 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Premature Birth, Counseling, Decision Making, Prenatal Care, Infant, Premature, Resuscitation
Interventions: Multimedia Information, Printed Handout; Other
Lead sponsor: Medical College of Wisconsin; Other
Eligibility: 18 Years and older
Enrollment: 76 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Fetal Hypoxia, Fetal Distress, Fetal Conditions, Fetal Complications, Labor Fetal Anoxia, Labor (Obstetrics)--Complications, Oxygen Deficiency
Interventions: Fetal Oxygenation Measurements; Device
Lead sponsor: Raydiant Oximetry, Inc.; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 35 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Norfolk, Virginia

Conditions: Fetal Growth Restriction, Fetal Growth Abnormality
Interventions: No intervention; Other
Lead sponsor: Katherine Grantz; NIH
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 2,809 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Post Term Pregnancy, Premature Rupture of Membrane, Fetal Growth Retardation, Oligohydramnios, Gestational Diabetes, High Blood Pressure in Pregnancy
Interventions: Dilapan-S; Device
Lead sponsor: Medicem Technology s.r.o.; Other
Eligibility: 18 Years and older · Female only
Enrollment: 1,200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2025
U.S. locations: 1
States / cities: Galveston, Texas

Search by objective public record fields.

Non-Invasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker

CAPO: Continuous Glucose Monitoring in A2 Gestational Diabetes and Pregnancy Outcomes

Phase II Randomized Study of Tin Mesoporphyrin for Neonatal Hyperbilirubinemia

Project CHOICES Efficacy Study

Congenital Heart Anomaly Risk in Maternal Enteroviral Infection and Diabetes

Multiple Gestation Study

PPROM Registry (Preterm Premature Rupture of Membranes)

Antibody Secreting Cell and Cyotokine Profiles in Neonates on ECMO

Misoprostol for Treatment of Fetal Death at 14-28 Weeks of Pregnancy

Extra Sitting Time After Spinal Anesthesia for Cesarean Section and Fetal Well-being

Maternal Newborn Health Registry

Pharmacokinetic and Safety Trial of Intravenous Levetiracetam in the Treatment of Neonatal Seizures

Elafibranor Pregnancy Surveillance Program: A Study to Evaluate the Safety of Elafibranor During Pregnancy

Preoperative Corticosteroid Therapy in Neonates Undergoing Cardiopulmonary Bypass

An Observational Pregnancy Safety Study in Women Who Were Exposed to the Drug Nifurtimox During Pregnancy to Learn About the Risk of Pregnancy Complications and About the Mother's and Baby's Health

Fetal Anatomy by Three-Dimensional Ultrasound

My Health Coach App RCT

The DC Mother-Infant Behavioral Wellness Program

Predicting the Need for Prolonged Respiratory Support in Neonates Delivered in a Lower-Level NICU Setting

Early DHA/ARA Supplementation in Growth-restricted Very Preterm Infants: A Randomized Clinical Trial

Counseling for Prematurity Using a Multimedia Education Tool

Trans-Abdominal Fetal Pulse Oximetry - EFS-IDE

Fetal 3D Study (Fetal Body Composition and Volumes Study)

Dilapan-S®: A Multicenter US E-registry